# CARB-X

CARB-X is an Asset Manager based in Boston, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** Boston, MA, United States
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** www.carb-x.org
- **LinkedIn:** https://www.linkedin.com/company/carb-x

## Regulatory record

- **Reports private funds:** No

## About

CARB-X is a global non-profit partnership founded in 2016 in Boston, Massachusetts. It accelerates antibacterial products to address drug-resistant bacteria. CARB-X's portfolio includes a diverse pipeline of new antibiotics, vaccines, rapid diagnostics, and other products.

## Sectors

- Healthcare Services

## People

- Kevin Outterson — Executive Director
- Andy Soares White — Chief Financial Officer

## Questions

### Who runs investment decisions at CARB-X?

Kevin Outterson serves as Executive Director and oversees project selection. Andy Soares White manages financial operations as Chief Financial Officer.

### How does CARB-X source proprietary deal flow?

CARB-X receives applications through open calls and referrals from BARDA, NIAID, and partner foundations. Technical review panels evaluate proposals for scientific merit and development stage.

### What investment stages does CARB-X typically target?

The firm focuses on seed, start-up, and growth stages within early-stage antimicrobial resistance development.

### Where does the underlying capital come from?

Primary funding originates from BARDA, with co-funding from Wellcome Trust, the Bill & Melinda Gates Foundation, and Novo Nordisk Foundation.

## Related profiles

- [Carbon Zero](https://altss.com/profile/carbon-zero)
- [Carbyne Investimentos](https://altss.com/profile/carbyne-investimentos)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/carb-x

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology